Showing results (2531-2540 of 2,574) with videos related to
Sort By:
Pageof 258
Translational Psychiatry|March 16, 2021
Predicting alcohol use disorder remission: a longitudinal multimodal multi-featured machine learning approachSivan Kinreich, Vivia V McCutcheon, Fazil Aliev, et al.Nature|April 10, 2015
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.Leukemia|January 10, 2022
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myelomaSatoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, et al.Scientific Reports|December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective studyTobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.Antimicrobial Agents and Chemotherapy|March 12, 2024
Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five casesSaima Aslam, Dwayne Roach, Mikeljon P Nikolich, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2024
Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin-Alaska, 2023Julia H Rogers, Benjamin Westley, Thomas Mego, et al.Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.Complex Psychiatry|March 10, 2025
Clinical, Genomic, and Neurophysiological Correlates of Lifetime Suicide Attempts among Individuals with an Alcohol Use DisorderPeter B Barr, Zoe Neale, Chris Chatzinakos, et al.Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with an alcohol use disorderPeter B Barr, Zoe Neale, Chris Chatzinakos, et al.Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.Pageof 258